BG108435A - Novel crystalline forms of 4-[4-[4-(hydroxydiphenyl methyl)-1-piperidinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochloride - Google Patents
Novel crystalline forms of 4-[4-[4-(hydroxydiphenyl methyl)-1-piperidinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochlorideInfo
- Publication number
- BG108435A BG108435A BG108435A BG10843503A BG108435A BG 108435 A BG108435 A BG 108435A BG 108435 A BG108435 A BG 108435A BG 10843503 A BG10843503 A BG 10843503A BG 108435 A BG108435 A BG 108435A
- Authority
- BG
- Bulgaria
- Prior art keywords
- alpha
- hydrochloride
- hydroxybutyl
- piperidinyl
- acetic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN484MA2001 | 2001-06-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG108435A true BG108435A (en) | 2004-12-30 |
Family
ID=34566868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG108435A BG108435A (en) | 2001-06-18 | 2003-12-11 | Novel crystalline forms of 4-[4-[4-(hydroxydiphenyl methyl)-1-piperidinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochloride |
Country Status (20)
| Country | Link |
|---|---|
| EP (2) | EP1399422A2 (xx) |
| JP (2) | JP2005507374A (xx) |
| KR (1) | KR20040015734A (xx) |
| CN (1) | CN100390145C (xx) |
| AU (1) | AU2001278094B2 (xx) |
| BG (1) | BG108435A (xx) |
| BR (1) | BR0117054A (xx) |
| CA (2) | CA2646802A1 (xx) |
| CO (1) | CO5540340A2 (xx) |
| CZ (1) | CZ20033358A3 (xx) |
| EE (1) | EE200400010A (xx) |
| HU (1) | HUP0401546A2 (xx) |
| IL (2) | IL159266A0 (xx) |
| MX (1) | MXPA03011728A (xx) |
| NZ (1) | NZ530118A (xx) |
| PL (1) | PL367632A1 (xx) |
| RU (1) | RU2269516C2 (xx) |
| SK (1) | SK15372003A3 (xx) |
| WO (1) | WO2002102777A2 (xx) |
| ZA (1) | ZA200309557B (xx) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0400299A2 (en) * | 2001-04-09 | 2007-08-28 | Teva Pharma | Polymorphs of fexofenadine hydrochloride |
| JP2005532356A (ja) | 2002-06-10 | 2005-10-27 | テバ ファーマシューティカル インダストリーズ リミティド | 塩酸フェキソフェナジンの多型体ｘｖｉ |
| GB0319935D0 (en) | 2003-08-26 | 2003-09-24 | Cipla Ltd | Polymorphs |
| US20050256163A1 (en) * | 2004-04-26 | 2005-11-17 | Ilan Kor | Crystalline forms of fexofenadine hydrochloride and processes for their preparation |
| ITMI20041143A1 (it) * | 2004-06-08 | 2004-09-08 | Dipharma Spa | Polimorfi di fexofenadina e procedimento per la loro preparazione |
| ITMI20041568A1 (it) * | 2004-07-30 | 2004-10-30 | Dipharma Spa | "polimorfi di fexofenadina base" |
| JP2008514641A (ja) * | 2004-09-28 | 2008-05-08 | テバ ファーマシューティカル インダストリーズ リミティド | 結晶形フェキソフェナジン、およびその調製方法 |
| WO2007007347A1 (en) * | 2005-07-07 | 2007-01-18 | Wockhardt Limited | Industrial process of fexofenadine hydrochloride with controlled side products |
| US20090306135A1 (en) | 2008-03-24 | 2009-12-10 | Mukesh Kumar Sharma | Stable amorphous fexofenadine hydrochloride |
| CN104072402B (zh) * | 2014-07-16 | 2016-08-17 | 昆山龙灯瑞迪制药有限公司 | 一种新结晶形式的盐酸非索非那定化合物及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4254129A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
| DK0766668T3 (da) * | 1994-05-18 | 2002-10-28 | Aventis Pharma Inc | Fremgangsmåde til fremstilling af vandfrie og hydratformer af som antihistaminer anvendelige piperidinderivater, polymorfer og pseudo-morfer deraf |
| US6153754A (en) * | 1995-12-21 | 2000-11-28 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
| IN191492B (xx) * | 1999-05-25 | 2003-12-06 | Ranbaxy Lab Ltd | |
| GB0018691D0 (en) * | 2000-07-28 | 2000-09-20 | Rolabo Sl | Process |
-
2001
- 2001-07-31 EE EEP200400010A patent/EE200400010A/xx unknown
- 2001-07-31 EP EP01956057A patent/EP1399422A2/en not_active Withdrawn
- 2001-07-31 JP JP2003505320A patent/JP2005507374A/ja active Pending
- 2001-07-31 RU RU2004101045/04A patent/RU2269516C2/ru not_active IP Right Cessation
- 2001-07-31 CA CA002646802A patent/CA2646802A1/en not_active Abandoned
- 2001-07-31 SK SK1537-2003A patent/SK15372003A3/sk unknown
- 2001-07-31 WO PCT/US2001/023994 patent/WO2002102777A2/en active IP Right Grant
- 2001-07-31 MX MXPA03011728A patent/MXPA03011728A/es active IP Right Grant
- 2001-07-31 CA CA002450858A patent/CA2450858C/en not_active Expired - Fee Related
- 2001-07-31 CZ CZ20033358A patent/CZ20033358A3/cs unknown
- 2001-07-31 IL IL15926601A patent/IL159266A0/xx unknown
- 2001-07-31 KR KR10-2003-7016163A patent/KR20040015734A/ko not_active Application Discontinuation
- 2001-07-31 NZ NZ530118A patent/NZ530118A/en unknown
- 2001-07-31 PL PL01367632A patent/PL367632A1/xx not_active Application Discontinuation
- 2001-07-31 CN CNB018233791A patent/CN100390145C/zh not_active Expired - Fee Related
- 2001-07-31 AU AU2001278094A patent/AU2001278094B2/en not_active Ceased
- 2001-07-31 BR BR0117054-6A patent/BR0117054A/pt not_active Application Discontinuation
- 2001-07-31 EP EP10010066A patent/EP2261209A1/en not_active Withdrawn
- 2001-07-31 HU HU0401546A patent/HUP0401546A2/hu unknown
-
2003
- 2003-12-09 ZA ZA200309557A patent/ZA200309557B/xx unknown
- 2003-12-09 IL IL159266A patent/IL159266A/en not_active IP Right Cessation
- 2003-12-11 BG BG108435A patent/BG108435A/xx unknown
- 2003-12-18 CO CO03110519A patent/CO5540340A2/es not_active Application Discontinuation
-
2007
- 2007-11-06 JP JP2007289084A patent/JP2008094848A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03011728A (es) | 2004-07-08 |
| WO2002102777A8 (en) | 2003-10-30 |
| ZA200309557B (en) | 2004-09-14 |
| NZ530118A (en) | 2007-05-31 |
| EP2261209A1 (en) | 2010-12-15 |
| WO2002102777A2 (en) | 2002-12-27 |
| JP2008094848A (ja) | 2008-04-24 |
| CN1518540A (zh) | 2004-08-04 |
| CZ20033358A3 (en) | 2004-04-14 |
| KR20040015734A (ko) | 2004-02-19 |
| CA2646802A1 (en) | 2002-12-27 |
| EE200400010A (et) | 2004-02-16 |
| CA2450858A1 (en) | 2002-12-27 |
| RU2004101045A (ru) | 2005-06-27 |
| IL159266A (en) | 2010-11-30 |
| BR0117054A (pt) | 2004-07-27 |
| AU2001278094B2 (en) | 2006-01-12 |
| EP1399422A2 (en) | 2004-03-24 |
| HUP0401546A2 (hu) | 2004-12-28 |
| PL367632A1 (en) | 2005-03-07 |
| IL159266A0 (en) | 2004-06-01 |
| CA2450858C (en) | 2009-04-07 |
| JP2005507374A (ja) | 2005-03-17 |
| RU2269516C2 (ru) | 2006-02-10 |
| SK15372003A3 (sk) | 2004-08-03 |
| WO2002102777A3 (en) | 2003-02-27 |
| CO5540340A2 (es) | 2005-07-29 |
| CN100390145C (zh) | 2008-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX367154B (es) | Formas solidas de acido 3-(6-(1-(2,2-difluorobenzo[d] [1,3]dioxol-5-il)ciclopropancarboxamido)-3-metilpiridin-2-il)benz oico. | |
| BG108435A (en) | Novel crystalline forms of 4-[4-[4-(hydroxydiphenyl methyl)-1-piperidinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochloride | |
| DK153709B (da) | Analogifremgangsmaade til fremstilling af 4-substituerede piperidinoalkanolderivater | |
| WO2007127297A3 (en) | Crystalline forms of a dimethylphenyl compound | |
| NO162819B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyleddiksyrederivater. | |
| NO319873B1 (no) | Fremgangsmate for fremstilling av antihistaminiske 4-difenylmetyl/difenylmetoksypiperidinderivater, nye mellomprodukter og anvendelse av disse | |
| TW200734038A (en) | Novel dispersant and compositions thereof | |
| AU2005272389A1 (en) | Novel cyclic aminobenzoic acid derivative | |
| CA2584833A1 (en) | Process for the synthesis of 4-(3-sulfonylphenyl)-piperidines | |
| EA200801518A1 (ru) | Новый способ получения высокочистого полиморфа (i) донепезила гидрохлорида | |
| PT721452E (pt) | Processo para a preparacao de derivados de sufentanilo por adicao de carbeno/aminolise de 4-piperidona | |
| IL180192A (en) | The result of arylamide, its salt and the antifungals that contain them | |
| KR20000064507A (ko) | 피페리딘유도체의제조방법 | |
| JP5673729B2 (ja) | ４−置換又は非置換テトラヒドロピラン−４−カルボン酸化合物又はそのエステル化合物の製法 | |
| JP2010536713A5 (xx) | ||
| CA2429563C (en) | Process for the preparation of donepezil | |
| NO20082474L (no) | Fremgangsmate for fremstilling av en leukotrienantagonist og intermediater derav | |
| JP5585822B2 (ja) | 光学活性ニペコチン酸誘導体の製造方法 | |
| TW200637856A (en) | Process for producing thiazolidinedion compound and intermediate thereof | |
| DK1489080T3 (da) | Fremgangsmåde til frembringelse af cilostazol | |
| PL353977A1 (en) | Method of obtaining 4-[1-hydroxy-4-[4-(hydroxydiphenyldimethyl)-1-piperidinylbutyl]-alpha,alpha-dimethylbenzene acetic acid | |
| AU2008288430A1 (en) | Novel preparation process | |
| NO20070776L (no) | Forbedret prosess for fremstilling av mirtazapin | |
| WO2009047797A3 (en) | Process for the preparation of perhydroisoindole derivative | |
| ZA200007034B (en) | Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof. |